Clinical Study Of Qianlie Tongqiao Ca Psule In Treating Benign Prostatic Hyperplasia With Chronic Prostatitis

Objective:To observe the clinical efficacy of Qianlie Tongqiao CaPsule in the treatment of benign Prostatic hyPerPlasia combined with chronic Prostatitis.Method:Sixty-eight patients who met the inclusion criteria were divided into a treatment group and a control group using a simple random method,with 34 cases in each group.The treatment group was given Qianlie Tongqiao Capsules + tamsulosin hydrochloride sustained-release capsules,and the control group was given Qianlieshu Pills + tamsulosin hydrochloride sustained-release capsules.The treatment for 8 weeks was a course of treatment.A total of 1 course of treatment was observed.The comprehensive efficacy,symptom improvement,IPSS,NIH-CPSI,bladder residual urine,prostate volume,maximum urinary flow rate,prostate fluid score,curative effect of TCM syndromes,and adverse reactions were compared between the two groups before and after treatment.Statistics,analysis and conclusions.Result:The treatment group was selected in 34 cases,the control group was selected in 34 cases,the treatment group was excluded in the middle of treatment in 4 cases,the control group was removed in the middle of treatment in 4 cases,and the final treatment group and the control group were effective cases in 30 cases.1.The total effective rate of the treatment group was 86.67%,9 cases were marke dly effective,18 cases were effective,and 3 cases were invalid;the total effective rate of the control group was 73.33%,including 4 cases of marked effect,18 cases of effective,and invalid There are 8 cases.Compared with the control group,the clinical effectiveness of the treatment group was better than that of the control group,the difference was statistically significant(P<0.05).2.The symptom improvement rate of patients in the treatment group was 83.33%,there were 9 cases of obvious improvement,16 cases of mild improvement,and 5 cases of no improvement;the symptom improvement rate of patients in the control group was 73.33%,including 7 There were 15 cases with mild improvement and 8cases without improvement.The symptom improvement degree was comparable between the two groups,with no significant difference(P>0.05).3.After treatment in both groups,the total TCM syndrome scores,TCM syndrome scores,and TCM secondary syndrome scores in the treatment group were lower tha n before treatment;the control group total TCM syndrome scores,TCM syndrome scores,and TCM secondary syndrome scores were all reduced.Decrease compared with before treatment.Both the treatment group and the control group can significantly improve the patients’ TCM symptoms(P<0.05).4.Comparison between the two groups of patients after treatment,the total score of TCM syndromes in the treatment group is significantly better than the control group(P<0.05);There was no significant difference between the treatment group and the control group in terms of syndrome scores(P>0.05).5.After treatment in both groups,the IPSS score,NIH-CPSI score,bladder residual urine score,maximum urinary flow rate score,and prostate fluid score of the treatment group were lower than before treatment(P<0.05),and the prostate volume score was more Before the decline,the difference was not significant(P>0.05);the control group’s IPSS score,NIH-CPSI score,bladder residual urine score,maximum urinary flow rate score,and prostate fluid score were significantly lower than before treatment(P<0.05),Prostate volume score decreased compared with before treatment but there was no significant difference(P>0.05).6.After treatment between two groups,the NIH-CPSI score of the treatment group was significantly lower than that of the control group,the difference was statistically significant(P<0.05),and the maximum urine flow rate score was significantly lower than that of the control group,The difference was statistically significant(P<0.05);the treatment group’s IPSS score,bladder residual urine score,prostate fluid score,and prostate volume score were lower than the control group’s IPSS score,bladder residual urine score,prostate fluid score,and prostate volume score,but There was no significant difference(P>0.05).7.There were 5 cases of mild adverse reactions in the treatment,including 2 cases in the treatment group and 3 cases in the control group.The incidence of adverse reactions in the two groups of patients was low,and the adverse reactions occurred during the treatment process were similar(P>0.05).Conclusion:Qianlie Tongqiao Capsule has good curative effect on patients with benign prostatic hyperplasia and chronic prostatitis(kidney deficiency and blood stasis syndrom e),especially in the aspects of comprehensive curative effect,total NIH-CPSI score,and maximum urine flow The efficacy of TCM syndromes and other aspects is superior to Qianlieshu Pills.